Hydroxyindoleacetic Acid - Metabolism
Research News and Information

Saturday, November 21, 2009

Serotonergic hyperinnervation and effective serotonin blockade in an FGF receptor developmental model of psychosis.

29 Jun 2009 The role of fibroblast growth factor receptors (FGFR) in normal brain development has been well-documented in transgenic and knock-out mouse models. Changes in FGF and its receptors have also been observed in schizophrenia and related developmental ... Read more...

The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats.

29 Jun 2009 Convergent evidence indicates that in later stages of Parkinson's disease raphestriatal serotonin neurons compensate for the loss of nigrostriatal dopamine neurons by converting and releasing dopamine derived from exogenous administration of the ... Read more...

Developmental vitamin D deficiency alters dopamine turnover in neonatal rat forebrain.

5 Jun 2009 There is growing evidence that low vitamin D impacts adversely on brain development. The current study investigated the impact of developmental vitamin D (DVD) deficiency on dopamine and serotonin metabolism in the neonatal rat brain. DVD-deficiency ... Read more...

Latest indexed articles for 'Hydroxyindoleacetic Acid - Metabolism'

These are the very latest articles for this heading:

• ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers. 26 Aug 2009
• Serotonergic hyperinnervation and effective serotonin blockade in an FGF receptor developmental model of psychosis. 29 Jun 2009
• The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats. 29 Jun 2009
• Developmental vitamin D deficiency alters dopamine turnover in neonatal rat forebrain. 5 Jun 2009
• Central l-proline attenuates stress-induced dopamine and serotonin metabolism in the chick forebrain. 16 May 2009
• Further investigation into the mechanism of tachykinin NK(2) receptor-triggered serotonin release from guinea-pig proximal colon. 6 May 2009
• Fluoxetine potentiates the effects of corticotropin-releasing factor on locomotor activity and serotonergic systems in the roughskin newt, Taricha granulosa. May 2009
• Learning strategies during fear conditioning. 29 Apr 2009
• Infantile hypokinetic-hypotonic syndrome due to two novel mutations of the tyrosine hydroxylase gene. 28 Apr 2009
• Augmentation of cocaine-sensitized dopamine release in the nucleus accumbens of adult mice following prenatal cocaine exposure. 15 Apr 2009
• The 5-HT2A receptor is mainly expressed in nociceptive sensory neurons in rat lumbar dorsal root ganglia. 7 Apr 2009
• Cognitive impairment of prefrontal-dependent decision-making in rats after the onset of chronic pain. 6 Apr 2009
• Chronic treatment with monoamine oxidase-B inhibitors decreases cocaine reward in mice. Apr 2009
• Serotonin, social status and sex change in the bluebanded goby Lythrypnus dalli. 31 Mar 2009
• Repeated administration of Nigella sativa decreases 5-HT turnover and produces anxiolytic effects in rats. 30 Mar 2009
• 5,7-dihydroxytryptamine injections into the prefrontal cortex and nucleus accumbens differently affect prepulse inhibition and baseline startle magnitude in rats. 19 Mar 2009
• Short-term erythrosine B-induced inhibition of the brain regional serotonergic activity suppresses motor activity (exploratory behavior) of young adult mammals. Mar 2009
• Behavioral and neurochemical profile of m-CPP following exposure to single restraint stress in rat. 27 Feb 2009
• Influence of intracerebroventricular or intraperitoneal administration of cannabinoid receptor agonist (WIN 55,212-2) and inverse agonist (AM 251) on the regulation of food intake and hypothalamic serotonin levels. 25 Feb 2009
• Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion. 18 Feb 2009

See a longer list of these articles.

Technical information about 'Hydroxyindoleacetic Acid'

Chemical name: 1H-Indole-3-acetic acid, 5-hydroxy-

Registry Number: 54-16-0

Descriptor UI: D006897

Alternative terms: Hydroxyindoleacetic Acid; Acid, Hydroxyindoleacetic; 5-Hydroxyindolamine Acetic Acid; 5 Hydroxyindolamine Acetic Acid; Acetic Acid, 5-Hydroxyindolamine; Acid, 5-Hydroxyindolamine Acetic; 5-HIAA; 5-Hydroxy-3-Indoleacetic Acid; 5 Hydroxy 3 Indoleacetic Acid; Acid, 5-Hydroxy-3-Indoleacetic;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D03.066.288.478; D03.438.473.404.478;

History Note: 66(64)

Technical Notes: DF: HIAA